Validating drug production processes need not be a headache, according to AI researchers who say machine learning (ML) could be a single answer to biopharma’s multivariate problem. The FDA defines ...

Daniel D. Pratt presents five perspectives on teaching gathered from several years of research across five different countries. These perspectives are presented in both theoretical and practical forms ...

The Chinese firm has pulled back the curtain to expose how the top labs may be building their next-generation models. Now things get interesting. When the Chinese firm DeepSeek dropped a large ...